Bone Drug Zometa Helps Fight Breast Cancer Spread

CHICAGO - A drug to prevent bone loss during breast cancer treatment also substantially cut the risk that the cancer would return, results that left doctors excited about a possible new way to fight the disease.

It is the first large study to affirm wider anti-cancer hopes for Zometa and other bone-building drugs called bisphosphonates. Zometa, made by Novartis AG, is used now for cancers that have already spread to the bone.

Read full story

More on This

• Celldex breast cancer drug shrinks some tumors-study
• Study unpicks gene changes behind breast cancer
• Mammograms may be worth risks for some in their 40s
• Hormone drugs may pose fewer risks for Chinese women

Tags

• Breast Cancer
• Osteoporosis

Add a CommentComments

There are no comments yet. Be the first one and get the conversation started!

Do you really want to post anonymously?

Are You a Member? Log InConnect your comment to your member profile. It only takes a second! Not a Member? Join Now!You'lll be automatically notified when someone else comments on your post.

Tell us what you think Write your comment here *

Leave this field blank

Receive email notifications of new comments Email Addresss

Sign me up for EmpowHER's FREE Newsletter!

Type in the characters above *

By hitting submit, you agree to EmpowHER's terms of service and privacy policy